Clinical Trials Logo
  1. Home
  2. Hemorrhoids
  3. NCT00160290
  4. Details
NCT00160290 Clinical Trial

Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures

Hemorrhoids Clinical Trial

Official title:
An Open, Randomized, Parallel Group, Single Center Study to Investigate the Effect of Lactulose Versus Plantago Ovate on the Quality of Life of Patients With Hard Stools and Hemorrhoids or Anal Fissure

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT00160290
Other study ID # S105.4.106
Secondary ID
Status Terminated
Phase Phase 4
First received September 9, 2005
Last updated April 29, 2008
Start date March 2002
Est. completion date June 2006

Study information
Verified date April 2008
Source Solvay Pharmaceuticals
Contact n/a
Is FDA regulated No
Health authority Spain: Spanish Agency of Medicines
Study type Interventional

Clinical Trial Summary

To demonstrate that lactulose acts as a stool softener, relieving the pain at defecation, improving the number of defecations and regulating the colonic transit time in patients suffering of hemorrhoids or anal fissure. To compare efficacy and quality of life in patients treated either with lactulose or plantago ovate.

Recruitment information / eligibility
Status Terminated
Enrollment 97
Est. completion date June 2006
Est. primary completion date June 2006
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients suffering from symptomatic hemorrhoids, or symptomatic anal fissure.

Exclusion Criteria:

- Patients suffering from malignant tumor in the intestine or the anal-rectal region, irritable colon, intestine inflammatory disease.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• Lactulose
15 mL / 12 hours
• Plantago ovata
3,5 g / 12 hours

Locations
Country Name City State
Spain Site 2 Barcelona
Spain Site 6 Granada
Spain Site 5 Huesca
Spain Site 7 Oviedo
Spain Site 4 Sabadell (Barcelona)
Spain Site 3 Sant Cugat del Vallès (Barcelona)
Spain Site 8 Santiago de Compostela
Spain Site 1 Valencia

Sponsors (1)
Lead Sponsor Collaborator
Solvay Pharmaceuticals

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Quality of life of patients with hard stools and hemorrhoids or anal fissure 6 weeks No
Secondary Gastrointestinal Symptoms Rating Scale 6 weeks No
Secondary Bristol stool consistency scale 6 weeks No
Secondary Number of episodes of rectal bleeding 6 weeks No
Secondary Need of rescue medication 6 weeks No
See also
  Status Clinical Trial Phase
Completed NCT06216223 - Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients N/A
Withdrawn NCT02851940 - Pain and Bleeding Following Hypertonic Saline Sclerotherapy Compared to Brand Ligation for Symptomatic Hemorrhoids N/A
Recruiting NCT02301052 - Evaluation of Allium Ampeloprasum Spp.Iranicum Cream Effect for the Management of Hemorrhoids Symptoms Phase 1/Phase 2
Completed NCT02216305 - HAL-RAR Versus Hemorrhoidectomy in the Treatment of Grade III-IV Hemorrhoids. Prospective, Randomized Trial N/A
Completed NCT02358174 - Hemorrhoids and Metalloproteinases, Observational Study N/A
Completed NCT01483833 - Efficacy Study of Iferanserin to Treat Hemorrhoids Phase 2
Completed NCT00397137 - Stapled Anopexy Versus Closed Haemorrhoidectomy for Haemorrhoids N/A
Completed NCT00841620 - Symptom Control 1-year After Circular Stapler Anopexy or Diathermy Excision for Prolapsed Haemorhoids Phase 4
Completed NCT06459739 - Effect of Sacral Erector Spinae Plane Block on Hemorrhoid and Pilonidal Sinus Surgery N/A
Completed NCT04276298 - Topical Analgesia Post-Haemorrhoidectomy Phase 2/Phase 3
Completed NCT04675177 - Polidocanol Foam VS Artery Ligation in Hemorrhoidal Disease Phase 2/Phase 3
Recruiting NCT05889962 - Ultrasound-guided Pudendal Nerve Block for Pain After Hemorrhoidectomy N/A
Recruiting NCT01961739 - Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids Phase 2/Phase 3
Active, not recruiting NCT02061176 - THD Versus Open Haemorrhoidectomy N/A
Withdrawn NCT00512044 - Local Versus General Anaesthesia in Stapled Hemorrhoidectomy Phase 4
Completed NCT04031131 - The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids Phase 2
Recruiting NCT04329364 - RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty Phase 2/Phase 3
Completed NCT05247333 - Implementation of a Minor Ailment Service in Community Pharmacy Practice N/A
Completed NCT04567485 - Impact of Moderate to Severe Pain in the Post-intervention Monitoring Room After Hemorrhoidectomy on the Length of Stay in the Outpatient Surgery Unit
Completed NCT03298997 - Ligation and Hemorrhoidopexy Technique Versus Ligation of Hemorrhoidal Arteries Using Ultrasound for Hemorrhoids N/A